Logotype for Skye Bioscience Inc

Skye Bioscience (SKYE) Proxy filing summary

Event summary combining transcript, slides, and related documents.

Logotype for Skye Bioscience Inc

Proxy filing summary

16 Apr, 2026

Voting matters and shareholder proposals

  • Election of six directors: Paul Grayson, Deborah Charych, Punit Dhillon, Annalisa Jenkins, Karen Smith, and Andrew J. Schwab, with board recommending a vote for all nominees.

  • Ratification of CBIZ CPAS P.C. as independent registered public accounting firm for the year ending December 31, 2026.

  • Approval of an amendment to increase authorized common stock from 100,000,000 to 300,000,000 shares.

  • Advisory vote on executive compensation as disclosed in the proxy statement.

  • Other business may be addressed as appropriate at the meeting or any adjournment.

Board of directors and corporate governance

  • Six director nominees are presented for election at the annual meeting.

Executive compensation and say-on-pay

  • Advisory vote scheduled on the compensation of named executive officers, following SEC disclosure rules.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more